These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9822231)

  • 1. Thrombin-antithrombin III complex in acute retinal vein occlusion.
    Iijima H; Gohdo T; Imai M; Tsukahara S
    Am J Ophthalmol; 1998 Nov; 126(5):677-82. PubMed ID: 9822231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombin-antithrombin III complex. Cause of venous vascular occlusion of the retina].
    Krüger K; Anger V; Haas D
    Ophthalmologe; 1992 Feb; 89(1):67-70. PubMed ID: 1581696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercoagulable states in patients with retinal venous occlusion.
    Abu El-Asrar AM; Abdel Gader AG; Al-Amro S; Al-Momen AK
    Doc Ophthalmol; 1998; 95(2):133-43. PubMed ID: 10431797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-antithrombin III complex in acute retinal vein occlusion.
    Sagripanti A; Nardi M; Evangelisti L; Poggi V
    Am J Ophthalmol; 1999 Jul; 128(1):124-5. PubMed ID: 10482117
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.
    Tekeli O; Gürsel E; Buyurgan H
    Acta Ophthalmol Scand; 1999 Dec; 77(6):628-30. PubMed ID: 10634552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of thrombin-antithrombin III complexes in major orthopedic surgery: relation to the onset of venous thromboembolism.
    Pazzagli M; Mazzantini D; Cella G; Rampin E; Palla A
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):228-31. PubMed ID: 10726018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitors of blood coagulation in vascular occlusion of the retina and optic nerve].
    Krüger K; Witt I
    Fortschr Ophthalmol; 1990; 87(2):178-81. PubMed ID: 2141589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation parameters in retinal arterial occlusion.
    Sagripanti A; Romani A; Ferretti A; Ragone MC; Baicchi U; Carpi A; Nardi M
    Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):480-3. PubMed ID: 10379608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between Interleukin-6 and Thrombin-Antithrombin III Complex Levels in Retinal Diseases.
    Ehrlich R; Zahavi A; Axer-Siegel R; Budnik I; Dreznik A; Dahbash M; Nisgav Y; Megiddo E; Kenet G; Weinberger D; Livnat T
    Curr Eye Res; 2017 Sep; 42(9):1269-1272. PubMed ID: 28632410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K
    Thromb Res; 1991 Aug; 63(4):469-72. PubMed ID: 1755000
    [No Abstract]   [Full Text] [Related]  

  • 11. In retinal vein occlusion platelet response to thrombin is increased.
    Leoncini G; Signorello MG; Segantin A; Giacobbe E; Armani U; Piana A; Camicione P
    Thromb Res; 2009 Dec; 124(6):e48-55. PubMed ID: 19660790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased thrombin synthesis in patients with fulminant hepatic failure and its treatment with antithrombin III evaluated by plasma levels of thrombin-antithrombin III complex].
    Tomiya T; Ogata I; Hayashi S; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2473. PubMed ID: 3065544
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.
    Bertram B; Remky A; Arend O; Wolf S; Reim M
    Ger J Ophthalmol; 1995 Nov; 4(6):332-5. PubMed ID: 8751097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment].
    Malukiewicz-Wiśniewska G; Kotschy M
    Klin Oczna; 2000; 102(4):267-70. PubMed ID: 11291298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish sample.
    Ates O
    Clin Lab Haematol; 2006 Dec; 28(6):391-2. PubMed ID: 17105492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient increase in thrombin generation during radiotherapy of uterine carcinoma: A preliminary study using thrombin-antithrombin III complex measurements.
    Uszýnski M; Miodónska J; Zekanowska E
    Gynecol Obstet Invest; 1998 Aug; 46(2):130-2. PubMed ID: 9701694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is activated factor VII associated with retinal vein occlusion?
    Kadayifçilar S; Ozatli D; Ozcebe O; Sener EC
    Br J Ophthalmol; 2001 Oct; 85(10):1174-8. PubMed ID: 11567960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal activities of protein C, protein S and antithrombin III in young patients with retinal vein occlusion.
    Guareschi G; Viganò D'Angelo S; Foresti V; Bandello F; D'Angelo A
    Haematologica; 1990; 75(5):483-4. PubMed ID: 2151449
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoclonal antibody that triggers deacylation of an intermediate thrombin-antithrombin III complex.
    Asakura S; Matsuda M; Yoshida N; Terukina S; Kihara H
    J Biol Chem; 1989 Aug; 264(23):13736-9. PubMed ID: 2474535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thrombin-antithrombin complex in rheumatoid arthritis.
    Cella G; Fiocco U; Palla A
    J Rheumatol; 1997 Feb; 24(2):410. PubMed ID: 9035011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.